• YouTube
    • Facebook

    GRESP GRESP

    • Início
    • Sobre Nós
      • Comissão Coordenadora
      • Objetivos
      • Grupos de Trabalho
        • Doença Pulmonar Obstrutiva Crónica
        • Asma e Rinite
        • Apneia do Sono e Cuidados Respiratórios Domiciliários
        • Doenças Infeciosas
        • Doenças Oncológicas Respiratórias
        • Reabilitação Respiratória
        • Tabagismo
        • Dispositivos inalatórios
        • Formação e Investigação
        • Prevenção
        • Comunicacao e Digital
        • Avaliação Funcional Respiratória
      • Patrocínio Científico
      • Novas Inscrições
    • Eventos
    • Recursos
      • Minuto GRESP
      • Folhetos / Guias práticos
      • Vídeos
        • Dispositivos Inalatórios e Técnica Inalatória
        • Reabilitação Respiratória
      • Testes e questionários
        • ADO Index
        • BODE e BODEx
        • DOSE
        • Measurement of Health-Related Quality of Life & Asthma Control
      • Recursos por tema
        • Asma e Rinite
        • DPOC
        • Avaliação funcional respiratória
        • SAOS e CRD
        • Dispositivos inalatórios e técnica inalatória
        • Doenças respiratórias infeciosas
        • Tabagismo
        • Vacinação
      • Leituras / Discussão
    • Galeria
    • Contatos
    • Links Úteis

    A Não Perder

    • Benzodiazepine use in COPD: empirical evidence from Norway
    • Treating tobacco dependence in older adults: a survey of primary care clinicians’ knowledge, attitudes, and practice
    • Influence of weather and atmospheric pollution on physical activity in patients with COPD
    • Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD
    • Respiratory viruses associated with community-acquired pneumonia in children: matched case–control study
    • [ BROKEN LINK ] RespiratoryAT@Glance 70 & 71
    • Comparticipação das Câmaras Expansoras – Portaria n.º 246/2015 de 14 de Agosto
    • Incidental findings on chest CT imaging are associated with increased COPD exacerbations and mortality
    • VitalQPlus: a potential screening tool for early diagnosis of COPD
    • Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data
    • Predictors of cost-effectiveness of selected COPD treatments in primary care: UNLOCK study protocol
    • An intervention with access to C-reactive protein rapid test reduces antibiotic overprescribing in acute exacerbations of chronic bronchitis and COPD
    • Psychological aspects in asthma: do psychological factors affect asthma management?
    • Treating tobacco dependence in older adults: a survey of primary care clinicians’ knowledge, attitudes, and practice
    • Policy bite: The modern primary care workforce
    • Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis
    • Planning for Action: The Impact of an Asthma Action Plan Decision Support Tool Integrated Into an Electronic Health Record (EHR) at a Large Health Care System
    • Towards better patient care: drugs to avoid in 2015
    • Respiratory infection British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together
    • Positioning new pharmacotherapies for COPD
    • Prospective Study on the Relationship of Obesity to Asthma Impairment and Risk
    • Clinical Relevance of Fixed Ratio vs Lower Limit of Normal
    • Randomised, double-blind, placebo-controlled crossover study to investigate different dosing regimens of olodaterol delivered via Respimat® in patients with moderate to severe persistent asthma
    • Policy Bite: Family doctors – what does the name really mean?
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12

    Gresp no Facebook

    Siga-nos no Facebook e fique a par de todas as novidades na área das doenças respiratórias.

    APMGFIPCRG

    Contatos

    Mail: gresp@apmgf.pt

    • Novas inscrições
    • Patrocínio científico

    Associação Portuguesa de Medicina Geral e Familiar

    Av. da República, 97 – 1.º
    1050-190 Lisboa – Portugal
    Telf. +351 217 615 250
    Fax: +351 217 933 145

    © 2025 GRESP. Todos os direitos reservados